Latest Episodes
0
Vitamin C for Septic Shock?
In 2017, Paul Marik published a single-center retrospective before-and-after study that demonstrated significant mortality benefit to patients with septic shock who received a cocktail...
0
COVID-19 Update - March 2020
In December 2019 a novel coronavirus (now named COVID-19) was identified as responsible for a cluster of pneumonia cases in Wuhan, China. As of...
0
Roc vs. Sux - The CURASMUR Trial
The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial...
0
Identifying and Treating EVALI
In recent years, the use of e-cigarette and vaping products has sharply risen. Concomitant with the increased use is an increase in patients presenting...
0
A Year in Review: Key Articles from the 2019 Critical Care Literature
A plethora of literature was published during the course of 2019. In this podcast, we review several key articles published in the 2019 critical...
0
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Up to one-third of patients with status epilepticus will not respond to benzodiazepines. Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied. The...